Skip to main content
NY Home homeNews home
Story

Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies - Financial Times

Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies  Financial Times Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga  Bloomberg Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera  Barron's Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer  CNBC MIKE DAVIS: Foreign weight-loss drugmaker seeks fat profits by gobbling up American upstart  Fox Business

Latest News